Kerin B. Adelson, MD, on Improving End-of-Life Planning and Reducing Futile Care
2016 Quality Care SymposiumKerin B. Adelson, MD, of the Yale Cancer Center, discusses the major healthcare cost drivers at the end of life—aggressive treatments, emergency room visits, and futile care—and strategies for improving value. (Abstract 3)
Related Videos
Steven Shak, MD, on Breast Cancer–Specific Mortality
Steven Shak, MD, of Genomic Health, discusses mortality among patients with early-stage hormone receptor–positive invasive breast cancer in the SEER database who were treated based...
Ethan Basch, MD, on Assessing Quality: Patient-Reported Data
Ethan Basch, MD, of the University of North Carolina at Chapel Hill, summarizes a session he chaired on the burgeoning use of patient-reported outcomes and wearable sensors in clin...
Dawn L. Hershman, MD, on Improving Quality and Safety With Multidisciplinary Teams
Dawn L. Hershman, MD, of Columbia University Medical Center, summarizes a joint ASCO/NCI session on this important topic, including the challenges and solutions.
Lee N. Newcomer, MD, on Assessing Quality: Payer Perspective
Lee N. Newcomer, MD, of the UnitedHealth Group, gives his perspective on how to assess quality in the age of precision medicine.
Allison Kurian, MD, on Assessing Quality in the Age of Precision Medicine
Allison Kurian, MD, of Stanford University School of Medicine, discusses pressing questions about the clinical utility and value of extended genomic testing and other forms of prec...
